Helo Max Thrombectomy System (HEL2090)
Endovascular Engineering · Decision date Sep 3, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the Helo Max Thrombectomy System (HEL2090) on September 3, 2026, under 510(k) number K261800. The applicant is Endovascular Engineering of Menlo Park, California, and the device falls under 21 CFR 870.5150 (Embolectomy Catheter), Class II, product codes QEW and KRA, in the cardiovascular specialty. SESE is a clearance, not a PMA approval. The submission is a traditional 510(k) not reviewed by a third party, and the public record lists no combination product status and no authorized predetermined change control plan.
The reviewed item is a larger-diameter configuration of the Helo Thrombectomy System, cited as primary predicate K252956, with the Inari/Stryker FlowTriever Retrieval/Aspiration System (K211013) as reference predicate. The summary describes a 20F aspiration catheter introduced through a 20 or 22 Fr sheath that expands to 11 mm distally, with an integrated handle and a separately packaged 14F dilator. Stated indications cover non-surgical removal of emboli and thrombi from pulmonary arteries and venous vasculature. Bench testing and ethylene oxide sterilization validation are summarized; clinical outcome data and the basis for the predicate comparison are not detailed in the excerpts provided.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261800
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Endovascular Engineering
- Product code
- QEW
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Peripheral Mechanical Thrombectomy With Aspiration.
- Applicant
- Endovascular Engineering
- Product code
- QEW
- FDA device class
- 2
FDA decision timeline
K261800 received
Application receipt date recorded by FDA.
K261800 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QEW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
INDIGO Aspiration SystemK262904 | Penumbra Inc. | 510(k) clearance | Oct 15, 2026 | FDA |
Triever Duo CatheterK253419 | Inari Medical, Inc. | 510(k) clearance | Sep 18, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Endovascular Engineering
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Menlo Park, CA
Sources and methodology
- Original FDA record: K261800
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
